Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02161133 · ClinicalTrials.gov registry record · NA

Cognitive Rehabilitation for Gulf War Illness

A NA study, sponsored by VA Office of Research and Development.

Completed
Registry status
NA
Development phase
268
Enrollment target

NCT02161133: Completed NA study, sponsored by VA Office of Research and Development.

NCT02161133 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 268 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (81% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT02161133, a NA study, has completed, sponsored by VA Office of Research and Development.

COMPLETED
Registry status
NA
Development phase
268 participants
Enrollment target

Study Summary

There are almost 700,000 Gulf War Veterans (GWV) with 25-30% suffering from a devastating multi-symptom illness coined Gulf War Illness (GWI). GWV with GWI report significant activity limitations and chronic cognitive problems consistent with problem-solving deficits. Problem-solving is considered the most complex of cognitive abilities and is what enables us to conduct complicated behaviors such as setting goals, sequencing and multi-tasking. As a result studies have found that problem-solving deficits are prospectively related to a greater risk of disability. Despite published reports documenting these problems there are no treatments that target the problem-solving deficits of GWI. This proposal seeks to determine whether Problem-Solving Therapy, a patient centered cognitive rehabilitation therapy, can reduce disability by compensating for problem-solving deficits.

Primary Outcome

World Health Organization Disability Assessment Schedule. The WHO-DAS 2.0 measures disability due to physical and mental health conditions. The WHO-DAS 2.0 is a 36 item measure that focuses upon six life tasks: * Understanding and communicating * Self-care * Mobility (getting around) * Interpersonal relationships (getting along with others) * Work and household roles (life activities) * Community and civic roles (participation) These six life tasks reflect two underlying constructs: Activity

Interventions

  • BEHAVIORAL Health Education
  • BEHAVIORAL Problem-Solving Therapy

Trial Details

FieldValue
Enrollment Target 268 participants
Start Date 2015-01-01
Est. Completion 2019-09-01
Phase NA
VA Office of Research and Development

1,668 total trials

What the finished NCT02161133 record still lists

NCT02161133 is an interventional study that assigns participants to a tested intervention. The registered 268 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (81% lower).

The record links to 0 conditions, and to 2 interventions - of which Health Education is the first listed.

NCT02161133 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02161133 about?

NCT02161133 is a clinical study titled "Cognitive Rehabilitation for Gulf War Illness". There are almost 700,000 Gulf War Veterans (GWV) with 25-30% suffering from a devastating multi-symptom illness coined Gulf War Illness (GWI). GWV with GWI report significant activity limitations and chronic cognitive problems consistent with problem-solving deficits. Problem-solving is considered t...

What is the current status of trial NCT02161133?

This trial is currently completed. It is a NA study. The enrollment target is 268 participants. The study started on 2015-01-01. Estimated completion is 2019-09-01.

What interventions are being tested in trial NCT02161133?

The interventions under investigation include: Health Education (BEHAVIORAL), Problem-Solving Therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT02161133?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02161133's enrollment target sits among peer trials

268 392nd of 2000 higher than 1,606 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05000632 · 268 participants · NA

    Smoke Free SafeCare: Establishing a Smoke Free Home in CPS-involved Families

  • NCT05797831 · 268 participants · Phase 2

    Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer

  • NCT05997381 · 268 participants · NA

    BioBrace® Implant for Arthroscopic Repair of Full Thickness Rotator Cuff Tears

  • NCT06233461 · 268 participants · Phase 2

    A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02161133, the US trial registry maintained by the National Library of Medicine. NCT02161133 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.